Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:12 am
| PEG Ratio | -3.54 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DCM Shriram Ltd operates in the diversified industry, reporting a market capitalization of ₹19,605 Cr and a current share price of ₹1,257. The company’s revenue from operations has shown a robust growth trajectory, with sales increasing from ₹9,627 Cr in FY 2022 to ₹11,547 Cr in FY 2023. For FY 2024, sales are reported at ₹10,922 Cr, while the trailing twelve months (TTM) revenue stands at ₹12,777 Cr. Quarterly sales figures indicate fluctuations; for instance, in the most recent quarter (September 2023), sales were ₹2,708 Cr, slightly lower than the ₹2,780 Cr recorded in June 2023. Notably, the company experienced a peak in sales in the December 2023 quarter, reaching ₹3,035 Cr. This suggests a volatile yet upward trend in revenue, underscoring DCM Shriram’s ability to adapt to market dynamics and harness growth opportunities.
Profitability and Efficiency Metrics
DCM Shriram’s profitability metrics illustrate a mixed performance. The operating profit margin (OPM) declined to 9% in FY 2023 from 19% in FY 2022, reflecting increased operational costs. The net profit for FY 2023 was reported at ₹911 Cr, which decreased to ₹447 Cr in FY 2024, but rebounded to ₹604 Cr in FY 2025. The company’s return on equity (ROE) stood at 8.66%, while the return on capital employed (ROCE) was recorded at 11.4%. Efficiency indicators, such as the cash conversion cycle (CCC), stood at 121 days, indicating a need for improved cash flow management. The interest coverage ratio (ICR) is robust at 9.63x, suggesting that the company can comfortably meet its interest obligations. Overall, while profitability has faced challenges, the company maintains a strong position in terms of its ability to generate returns on investment.
Balance Sheet Strength and Financial Ratios
DCM Shriram’s balance sheet reflects a solid financial foundation, with total liabilities amounting to ₹12,731 Cr against total assets of ₹12,731 Cr as of FY 2025. Reserves have grown to ₹7,194 Cr, indicating a strong retained earnings position. The borrowings stood at ₹2,177 Cr, demonstrating prudent debt management with a debt-to-equity ratio of 0.34x. The company reported a book value per share of ₹446.83, an increase from ₹416.08 in FY 2024. The current ratio is healthy at 1.58, indicating sufficient liquidity to meet short-term obligations. However, the quick ratio of 0.71 suggests potential liquidity constraints. The enterprise value (EV) is reported at ₹18,275.09 Cr, with an EV/EBITDA ratio of 12.41x, which is relatively high compared to sector norms, indicating that the stock may be overvalued based on its earnings potential. Overall, the balance sheet is robust, but careful monitoring of liquidity ratios is essential for future stability.
Shareholding Pattern and Investor Confidence
DCM Shriram has a stable shareholding structure, with promoters holding a substantial 66.53% stake. This strong promoter backing provides a level of confidence to investors regarding the company’s long-term vision and governance. Foreign institutional investors (FIIs) account for 3.97% of the shareholding, while domestic institutional investors (DIIs) hold 8.24%. The public shareholding stands at 20.54%, reflecting a diverse base of retail investors. The number of shareholders has increased to 60,864, indicating growing interest in the stock. Despite the fluctuations in share price and profitability, the consistent promoter holding suggests that insiders remain confident in the company’s prospects. However, the relatively low FII participation could indicate limited international confidence, which may affect stock liquidity and overall market perception.
Outlook, Risks, and Final Insight
The outlook for DCM Shriram appears cautiously optimistic, given its strong fundamentals and growth potential. Key strengths include a robust balance sheet, a solid interest coverage ratio, and a diverse revenue stream. However, risks such as fluctuating profitability, a declining OPM, and potential liquidity constraints due to lower quick ratios could pose challenges. The company must focus on improving operational efficiency and managing costs effectively to enhance profitability. Additionally, addressing cash flow management and liquidity ratios will be crucial for sustaining growth. In a scenario where operational efficiencies improve and market conditions stabilize, DCM Shriram may leverage its strong market position to enhance shareholder value significantly. Conversely, continued volatility in sales and profit margins could hinder growth prospects, necessitating strategic adjustments to navigate market fluctuations effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 8,779 Cr. | 1,246 | 1,639/842 | 21.2 | 397 | 0.52 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 19,605 Cr. | 1,257 | 1,502/903 | 27.5 | 463 | 0.72 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 3,154 Cr. | 184 | 238/147 | 11.9 | 114 | 4.61 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 40,764 Cr. | 36,170 | 37,385/25,714 | 66.7 | 1,906 | 0.44 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 18,075.50 Cr | 9,714.25 | 31.83 | 720.00 | 1.57% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,740 | 3,236 | 2,720 | 2,780 | 2,708 | 3,035 | 2,399 | 2,876 | 2,957 | 3,367 | 2,877 | 3,262 | 3,272 |
| Expenses | 2,470 | 2,682 | 2,374 | 2,614 | 2,594 | 2,590 | 2,134 | 2,629 | 2,776 | 2,871 | 2,472 | 2,958 | 2,963 |
| Operating Profit | 270 | 554 | 346 | 166 | 114 | 445 | 265 | 248 | 181 | 496 | 405 | 304 | 309 |
| OPM % | 10% | 17% | 13% | 6% | 4% | 15% | 11% | 9% | 6% | 15% | 14% | 9% | 9% |
| Other Income | 32 | 33 | 26 | 17 | 22 | 35 | 24 | 26 | 54 | 41 | 21 | 22 | 99 |
| Interest | 11 | 13 | 12 | 25 | 15 | 15 | 32 | 29 | 38 | 43 | 43 | 44 | 43 |
| Depreciation | 63 | 66 | 71 | 72 | 74 | 77 | 80 | 86 | 101 | 109 | 114 | 112 | 119 |
| Profit before tax | 228 | 509 | 289 | 86 | 47 | 389 | 177 | 158 | 96 | 386 | 270 | 170 | 246 |
| Tax % | 44% | 33% | 35% | 34% | 32% | 38% | 33% | 37% | 34% | 32% | 34% | 33% | 35% |
| Net Profit | 128 | 342 | 187 | 57 | 32 | 240 | 118 | 100 | 63 | 262 | 179 | 114 | 159 |
| EPS in Rs | 8.22 | 21.94 | 11.97 | 3.63 | 2.07 | 15.42 | 7.55 | 6.43 | 4.03 | 16.81 | 11.47 | 7.27 | 10.13 |
Last Updated: January 2, 2026, 12:03 am
Below is a detailed analysis of the quarterly data for DCM Shriram Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,272.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,262.00 Cr. (Jun 2025) to 3,272.00 Cr., marking an increase of 10.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,963.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,958.00 Cr. (Jun 2025) to 2,963.00 Cr., marking an increase of 5.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 309.00 Cr.. The value appears strong and on an upward trend. It has increased from 304.00 Cr. (Jun 2025) to 309.00 Cr., marking an increase of 5.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 9.00%.
- For Other Income, as of Sep 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Jun 2025) to 99.00 Cr., marking an increase of 77.00 Cr..
- For Interest, as of Sep 2025, the value is 43.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.00 Cr. (Jun 2025) to 43.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 119.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 112.00 Cr. (Jun 2025) to 119.00 Cr., marking an increase of 7.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 246.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Jun 2025) to 246.00 Cr., marking an increase of 76.00 Cr..
- For Tax %, as of Sep 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 33.00% (Jun 2025) to 35.00%, marking an increase of 2.00%.
- For Net Profit, as of Sep 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 114.00 Cr. (Jun 2025) to 159.00 Cr., marking an increase of 45.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 10.13. The value appears strong and on an upward trend. It has increased from 7.27 (Jun 2025) to 10.13, marking an increase of 2.86.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,182 | 5,639 | 5,780 | 5,788 | 6,900 | 7,771 | 7,767 | 8,308 | 9,627 | 11,547 | 10,922 | 12,077 | 12,777 |
| Expenses | 5,673 | 5,240 | 5,276 | 5,017 | 5,866 | 6,402 | 6,575 | 7,156 | 7,831 | 9,941 | 9,932 | 10,747 | 11,263 |
| Operating Profit | 509 | 399 | 505 | 771 | 1,035 | 1,369 | 1,192 | 1,152 | 1,796 | 1,606 | 991 | 1,330 | 1,514 |
| OPM % | 8% | 7% | 9% | 13% | 15% | 18% | 15% | 14% | 19% | 14% | 9% | 11% | 12% |
| Other Income | 50 | 52 | 41 | 47 | 56 | 88 | 88 | 92 | 92 | 120 | 99 | 142 | 183 |
| Interest | 149 | 112 | 85 | 71 | 83 | 119 | 164 | 122 | 85 | 53 | 88 | 153 | 172 |
| Depreciation | 138 | 110 | 98 | 114 | 141 | 157 | 219 | 233 | 238 | 260 | 303 | 410 | 453 |
| Profit before tax | 272 | 228 | 362 | 633 | 867 | 1,180 | 897 | 889 | 1,565 | 1,413 | 699 | 909 | 1,071 |
| Tax % | 11% | 8% | 17% | 13% | 23% | 24% | 20% | 24% | 32% | 36% | 36% | 34% | |
| Net Profit | 242 | 211 | 301 | 552 | 669 | 904 | 722 | 674 | 1,067 | 911 | 447 | 604 | 714 |
| EPS in Rs | 14.85 | 12.98 | 18.58 | 33.97 | 41.22 | 56.99 | 45.96 | 43.17 | 68.45 | 58.41 | 28.67 | 38.75 | 45.68 |
| Dividend Payout % | 14% | 17% | 17% | 17% | 20% | 17% | 18% | 22% | 22% | 24% | 23% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -12.81% | 42.65% | 83.39% | 21.20% | 35.13% | -20.13% | -6.65% | 58.31% | -14.62% | -50.93% | 35.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 55.46% | 40.73% | -62.19% | 13.93% | -55.26% | 13.48% | 64.96% | -72.93% | -36.31% | 86.06% |
DCM Shriram Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -4% |
| 3 Years: | -18% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 28% |
| 3 Years: | 6% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 13% |
| 3 Years: | 10% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 2:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 33 | 33 | 33 | 33 | 33 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 1,654 | 1,826 | 2,058 | 2,495 | 3,007 | 3,494 | 4,018 | 4,617 | 5,470 | 6,162 | 6,491 | 6,973 | 7,194 |
| Borrowings | 1,177 | 760 | 1,064 | 1,074 | 756 | 1,610 | 2,150 | 1,521 | 1,577 | 1,707 | 2,152 | 2,529 | 2,177 |
| Other Liabilities | 1,988 | 1,798 | 1,852 | 1,972 | 1,857 | 2,001 | 1,935 | 1,621 | 2,290 | 2,819 | 2,874 | 3,198 | 3,819 |
| Total Liabilities | 4,852 | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,731 | 13,221 |
| Fixed Assets | 1,513 | 1,443 | 1,428 | 2,022 | 2,211 | 2,690 | 3,499 | 3,360 | 3,408 | 4,105 | 4,222 | 6,517 | 6,920 |
| CWIP | 51 | 62 | 357 | 65 | 117 | 332 | 59 | 109 | 494 | 1,630 | 2,615 | 834 | 821 |
| Investments | 203 | 6 | 35 | 31 | 30 | 31 | 29 | 30 | 3 | 12 | 54 | 56 | 73 |
| Other Assets | 3,085 | 2,906 | 3,186 | 3,457 | 3,294 | 4,084 | 4,548 | 4,291 | 5,463 | 4,973 | 4,656 | 5,324 | 5,406 |
| Total Assets | 4,852 | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,731 | 13,221 |
Below is a detailed analysis of the balance sheet data for DCM Shriram Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
- For Reserves, as of Sep 2025, the value is 7,194.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,973.00 Cr. (Mar 2025) to 7,194.00 Cr., marking an increase of 221.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,177.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,529.00 Cr. (Mar 2025) to 2,177.00 Cr., marking a decrease of 352.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,819.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,198.00 Cr. (Mar 2025) to 3,819.00 Cr., marking an increase of 621.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 13,221.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12,731.00 Cr. (Mar 2025) to 13,221.00 Cr., marking an increase of 490.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6,920.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,517.00 Cr. (Mar 2025) to 6,920.00 Cr., marking an increase of 403.00 Cr..
- For CWIP, as of Sep 2025, the value is 821.00 Cr.. The value appears to be declining and may need further review. It has decreased from 834.00 Cr. (Mar 2025) to 821.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 17.00 Cr..
- For Other Assets, as of Sep 2025, the value is 5,406.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,324.00 Cr. (Mar 2025) to 5,406.00 Cr., marking an increase of 82.00 Cr..
- For Total Assets, as of Sep 2025, the value is 13,221.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,731.00 Cr. (Mar 2025) to 13,221.00 Cr., marking an increase of 490.00 Cr..
Notably, the Reserves (7,194.00 Cr.) exceed the Borrowings (2,177.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 508.00 | -361.00 | 504.00 | 770.00 | -755.00 | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | 989.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 69 | 81 | 63 | 48 | 49 | 51 | 23 | 34 | 27 | 22 | 28 |
| Inventory Days | 105 | 120 | 141 | 194 | 163 | 190 | 208 | 146 | 190 | 153 | 168 | 162 |
| Days Payable | 120 | 119 | 123 | 138 | 110 | 113 | 89 | 57 | 79 | 65 | 65 | 69 |
| Cash Conversion Cycle | 47 | 71 | 100 | 120 | 100 | 126 | 170 | 111 | 145 | 115 | 124 | 121 |
| Working Capital Days | 21 | 43 | 31 | 35 | 57 | 48 | 52 | 44 | 45 | 37 | 34 | 26 |
| ROCE % | 14% | 12% | 15% | 21% | 25% | 29% | 19% | 16% | 24% | 19% | 9% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Smallcap Fund | 339,557 | 0.49 | 41.29 | N/A | N/A | N/A |
| UTI Large & Mid Cap Fund | 254,637 | 0.56 | 30.96 | 252,748 | 2025-12-15 00:33:44 | 0.75% |
| UTI Aggressive Hybrid Fund | 235,271 | 0.43 | 28.61 | 233,384 | 2025-12-15 00:33:44 | 0.81% |
| UTI Retirement Fund | 107,359 | 0.27 | 13.05 | 107,200 | 2025-12-15 00:33:44 | 0.15% |
| ICICI Prudential Commodities Fund | 16,243 | 0.06 | 1.98 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 38.75 | 28.67 | 58.41 | 68.45 | 43.17 |
| Diluted EPS (Rs.) | 38.75 | 28.67 | 58.41 | 68.45 | 43.17 |
| Cash EPS (Rs.) | 64.72 | 47.85 | 74.70 | 83.19 | 57.76 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 446.83 | 416.08 | 395.14 | 350.99 | 296.53 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 446.83 | 416.08 | 395.14 | 350.99 | 296.53 |
| Revenue From Operations / Share (Rs.) | 770.48 | 696.81 | 736.65 | 614.19 | 530.03 |
| PBDIT / Share (Rs.) | 93.93 | 69.49 | 110.12 | 120.47 | 79.39 |
| PBIT / Share (Rs.) | 67.77 | 50.16 | 93.52 | 105.29 | 64.51 |
| PBT / Share (Rs.) | 58.02 | 44.58 | 90.15 | 99.84 | 56.73 |
| Net Profit / Share (Rs.) | 38.55 | 28.52 | 58.11 | 68.01 | 42.89 |
| NP After MI And SOA / Share (Rs.) | 38.55 | 28.52 | 58.11 | 68.09 | 42.96 |
| PBDIT Margin (%) | 12.19 | 9.97 | 14.94 | 19.61 | 14.97 |
| PBIT Margin (%) | 8.79 | 7.19 | 12.69 | 17.14 | 12.17 |
| PBT Margin (%) | 7.52 | 6.39 | 12.23 | 16.25 | 10.70 |
| Net Profit Margin (%) | 5.00 | 4.09 | 7.88 | 11.07 | 8.09 |
| NP After MI And SOA Margin (%) | 5.00 | 4.09 | 7.88 | 11.08 | 8.10 |
| Return on Networth / Equity (%) | 8.62 | 6.85 | 14.70 | 19.40 | 14.48 |
| Return on Capital Employeed (%) | 11.19 | 8.95 | 17.97 | 23.60 | 16.93 |
| Return On Assets (%) | 4.74 | 3.87 | 8.49 | 11.39 | 8.64 |
| Long Term Debt / Equity (X) | 0.19 | 0.21 | 0.18 | 0.17 | 0.21 |
| Total Debt / Equity (X) | 0.34 | 0.31 | 0.26 | 0.27 | 0.27 |
| Asset Turnover Ratio (%) | 0.99 | 0.98 | 1.15 | 1.11 | 1.03 |
| Current Ratio (X) | 1.58 | 1.62 | 1.84 | 2.18 | 2.29 |
| Quick Ratio (X) | 0.71 | 0.64 | 0.90 | 1.21 | 1.30 |
| Inventory Turnover Ratio (X) | 4.41 | 2.09 | 2.04 | 1.92 | 1.68 |
| Dividend Payout Ratio (NP) (%) | 21.04 | 26.50 | 26.19 | 19.86 | -12.73 |
| Dividend Payout Ratio (CP) (%) | 12.53 | 15.80 | 20.37 | 16.24 | -9.46 |
| Earning Retention Ratio (%) | 78.96 | 73.50 | 73.81 | 80.14 | 0.00 |
| Cash Earning Retention Ratio (%) | 87.47 | 84.20 | 79.63 | 83.76 | 0.00 |
| Interest Coverage Ratio (X) | 9.63 | 12.44 | 32.69 | 22.12 | 10.20 |
| Interest Coverage Ratio (Post Tax) (X) | 4.95 | 6.11 | 18.25 | 13.49 | 6.51 |
| Enterprise Value (Cr.) | 18275.09 | 14894.61 | 12389.38 | 17624.91 | 7800.09 |
| EV / Net Operating Revenue (X) | 1.51 | 1.36 | 1.07 | 1.83 | 0.93 |
| EV / EBITDA (X) | 12.41 | 13.67 | 7.18 | 9.33 | 6.27 |
| MarketCap / Net Operating Revenue (X) | 1.40 | 1.23 | 1.02 | 1.84 | 0.94 |
| Retention Ratios (%) | 78.95 | 73.49 | 73.80 | 80.13 | 0.00 |
| Price / BV (X) | 2.41 | 2.07 | 1.89 | 3.22 | 1.69 |
| Price / Net Operating Revenue (X) | 1.40 | 1.23 | 1.02 | 1.84 | 0.94 |
| EarningsYield | 0.03 | 0.03 | 0.07 | 0.06 | 0.08 |
After reviewing the key financial ratios for DCM Shriram Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 38.75. This value is within the healthy range. It has increased from 28.67 (Mar 24) to 38.75, marking an increase of 10.08.
- For Diluted EPS (Rs.), as of Mar 25, the value is 38.75. This value is within the healthy range. It has increased from 28.67 (Mar 24) to 38.75, marking an increase of 10.08.
- For Cash EPS (Rs.), as of Mar 25, the value is 64.72. This value is within the healthy range. It has increased from 47.85 (Mar 24) to 64.72, marking an increase of 16.87.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 446.83. It has increased from 416.08 (Mar 24) to 446.83, marking an increase of 30.75.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 446.83. It has increased from 416.08 (Mar 24) to 446.83, marking an increase of 30.75.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 770.48. It has increased from 696.81 (Mar 24) to 770.48, marking an increase of 73.67.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 93.93. This value is within the healthy range. It has increased from 69.49 (Mar 24) to 93.93, marking an increase of 24.44.
- For PBIT / Share (Rs.), as of Mar 25, the value is 67.77. This value is within the healthy range. It has increased from 50.16 (Mar 24) to 67.77, marking an increase of 17.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 58.02. This value is within the healthy range. It has increased from 44.58 (Mar 24) to 58.02, marking an increase of 13.44.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has increased from 28.52 (Mar 24) to 38.55, marking an increase of 10.03.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has increased from 28.52 (Mar 24) to 38.55, marking an increase of 10.03.
- For PBDIT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 9.97 (Mar 24) to 12.19, marking an increase of 2.22.
- For PBIT Margin (%), as of Mar 25, the value is 8.79. This value is below the healthy minimum of 10. It has increased from 7.19 (Mar 24) to 8.79, marking an increase of 1.60.
- For PBT Margin (%), as of Mar 25, the value is 7.52. This value is below the healthy minimum of 10. It has increased from 6.39 (Mar 24) to 7.52, marking an increase of 1.13.
- For Net Profit Margin (%), as of Mar 25, the value is 5.00. This value is within the healthy range. It has increased from 4.09 (Mar 24) to 5.00, marking an increase of 0.91.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.00. This value is below the healthy minimum of 8. It has increased from 4.09 (Mar 24) to 5.00, marking an increase of 0.91.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.62. This value is below the healthy minimum of 15. It has increased from 6.85 (Mar 24) to 8.62, marking an increase of 1.77.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 8.95 (Mar 24) to 11.19, marking an increase of 2.24.
- For Return On Assets (%), as of Mar 25, the value is 4.74. This value is below the healthy minimum of 5. It has increased from 3.87 (Mar 24) to 4.74, marking an increase of 0.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.34. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 0.34, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has increased from 0.98 (Mar 24) to 0.99, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.62 (Mar 24) to 1.58, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.71, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.41. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 4.41, marking an increase of 2.32.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 21.04. This value is within the healthy range. It has decreased from 26.50 (Mar 24) to 21.04, marking a decrease of 5.46.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.53. This value is below the healthy minimum of 20. It has decreased from 15.80 (Mar 24) to 12.53, marking a decrease of 3.27.
- For Earning Retention Ratio (%), as of Mar 25, the value is 78.96. This value exceeds the healthy maximum of 70. It has increased from 73.50 (Mar 24) to 78.96, marking an increase of 5.46.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.47. This value exceeds the healthy maximum of 70. It has increased from 84.20 (Mar 24) to 87.47, marking an increase of 3.27.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.63. This value is within the healthy range. It has decreased from 12.44 (Mar 24) to 9.63, marking a decrease of 2.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.95. This value is within the healthy range. It has decreased from 6.11 (Mar 24) to 4.95, marking a decrease of 1.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 18,275.09. It has increased from 14,894.61 (Mar 24) to 18,275.09, marking an increase of 3,380.48.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.36 (Mar 24) to 1.51, marking an increase of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 13.67 (Mar 24) to 12.41, marking a decrease of 1.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.40, marking an increase of 0.17.
- For Retention Ratios (%), as of Mar 25, the value is 78.95. This value exceeds the healthy maximum of 70. It has increased from 73.49 (Mar 24) to 78.95, marking an increase of 5.46.
- For Price / BV (X), as of Mar 25, the value is 2.41. This value is within the healthy range. It has increased from 2.07 (Mar 24) to 2.41, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.40, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DCM Shriram Ltd:
- Net Profit Margin: 5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.19% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.62% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27.5 (Industry average Stock P/E: 31.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.34
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Diversified | 2nd Floor (West Wing), New Delhi Delhi 110037 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ajay S Shriram | Chairman & Sr.Mng.Director |
| Mr. Vikram S Shriram | Vice Chairman & Mng.Director |
| Mr. Ajit S Shriram | Joint Managing Director |
| Mr. Aditya A Shriram | Deputy Managing Director |
| Mr. K K Sharma | Whole Time Director |
| Mr. Pradeep Dinodia | Non Executive Director |
| Mr. Pravesh Sharma | Ind. Non-Executive Director |
| Justice(Retd) Vikramajit Sen | Ind. Non-Executive Director |
| Mr. Pranam Wahi | Ind. Non-Executive Director |
| Ms. Seema Bahuguna | Ind. Non-Executive Director |
| Dr. Simrit Kaur | Ind. Non-Executive Director |
| Mr. Vipin Sondhi | Ind. Non-Executive Director |
| Mr. Tejpreet Singh Chopra | Ind. Non-Executive Director |
| Mr. Rabinarayan Mishra | Nominee Director |
FAQ
What is the intrinsic value of DCM Shriram Ltd?
DCM Shriram Ltd's intrinsic value (as of 04 January 2026) is ₹888.46 which is 29.32% lower the current market price of ₹1,257.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹19,605 Cr. market cap, FY2025-2026 high/low of ₹1,502/903, reserves of ₹7,194 Cr, and liabilities of ₹13,221 Cr.
What is the Market Cap of DCM Shriram Ltd?
The Market Cap of DCM Shriram Ltd is 19,605 Cr..
What is the current Stock Price of DCM Shriram Ltd as on 04 January 2026?
The current stock price of DCM Shriram Ltd as on 04 January 2026 is ₹1,257.
What is the High / Low of DCM Shriram Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DCM Shriram Ltd stocks is ₹1,502/903.
What is the Stock P/E of DCM Shriram Ltd?
The Stock P/E of DCM Shriram Ltd is 27.5.
What is the Book Value of DCM Shriram Ltd?
The Book Value of DCM Shriram Ltd is 463.
What is the Dividend Yield of DCM Shriram Ltd?
The Dividend Yield of DCM Shriram Ltd is 0.72 %.
What is the ROCE of DCM Shriram Ltd?
The ROCE of DCM Shriram Ltd is 11.4 %.
What is the ROE of DCM Shriram Ltd?
The ROE of DCM Shriram Ltd is 8.66 %.
What is the Face Value of DCM Shriram Ltd?
The Face Value of DCM Shriram Ltd is 2.00.